Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04150497
Brief Title: Phase I Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

First Submitted : November 1, 2019
First Submitted that Met QC Criteria : November 1, 2019
First Posted : November 4, 2019

Last Update Submitted that Met QC Criteria : May 27, 2020
Last Update Posted : May 28, 2020